| DARE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DARE market cap history going back to 7/20/2017:
Also see: DARE Shares Outstanding History and DARE YTD Return |
DARE Market Cap History — Dare Bioscience Capitalization Over Time
As of 5/13/2026 Dare Bioscience has a market cap of 42.54 million. Investors often follow the DARE market cap history to compare the size of the company over time.
This page shows DARE market capitalization trends over time, with 35 market cap datapoints presented, dating back to 7/20/2017.
| DARE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DARE Historical Market Cap: +1.82% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DARE Stock Price Chart |
| About Dare Bioscience Inc |
| Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Co.'s U.S. Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1; DARE-VVA1; DARE-CIN; DARE-PDM1; DARE-204 and DARE-214, and DARE-FRT1 and DARE-PTB1. Its pre-clinical stage programs include DARE-LARC1, DARE-LBT, DARE-GML, DARE-RH1 and DARE-PTB2. We show 35 historical shares outstanding datapoints in our DARE shares outstanding history coverage, used to compute DARE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DARE market cap history over the course of time is important for investors interested in comparing DARE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DARE versus a peer is one thing; comparing DARE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DARE can fluctuate over the course of history. With this page we aim to empower investors researching DARE by allowing them to research the DARE market cap history. |
| DARE Current Stock Quote |
Quotes delayed 20 minutes  Free DARE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| DARE Share Performance |
| Market Cap Peers |
| Dare Bioscience (DARE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DAWN Market Cap History DBTX Market Cap History DCGO Market Cap History DCOY Market Cap History DCPH Market Cap History DCTH Market Cap History DEPO Market Cap History DERM Market Cap History DFFN Market Cap History DGX Market Cap History More Healthcare companies » |
DARE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
